HIV-1 gp120 (V2V5 corridor) Specific Neutra™ Antibody (V3S-0923-XY28), Human IgG1 (CAT#: V3S-0923-XY28)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is a human antibody recognizing HIV-1 gp120, termed as M1214_N1. The epitope of M1214_N1 extends from V2 to V5 and centered on the ridge of the CD4-binding loop. It exhibited the best breadth (65%) and potency against the HIV-1. This product has been tested by Enzyme-linked immunosorbent assay, Flow cytometry and Neutralization assay.
Clonality Monoclonal
Host Species Human
Target Species HIV-1
Epitope V2V5 corridor
Neutralization Breath 65% (against HIV-1)
Isotype Human IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; FC; Neut
Application Notes ELISA: After blocking with 1% BSA in PBS at 37°C for 1 h, serially diluted antibody was incubated at 37°C for 1 h.
Neutralization assay (Neut): 50 or 100 μL of antibody-virus mixture was incubated at 37°C for 30 min in duplicate wells before the addition of TZM-bl cells.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target HIV-1 gp120
Alternative Name Human immunodeficiencyvirus-1 glycoprotein 120
Research Area Infectious Disease
Related Disease Acquired Immune Deficiency Syndrome
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry